Roka Bioscience Inc (ROKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,832 | 3,441 | 7,503 | 32,728 | N/A |
| Marketable Securities | 16,001 | 28,809 | 36,231 | N/A | N/A |
| Receivables | 930 | 649 | 670 | 277 | N/A |
| Inventories | 3,739 | 3,939 | 4,930 | 3,879 | N/A |
| Income taxes - deferred | N/A | N/A | N/A | 3,135 | N/A |
| TOTAL | $35,116 | $42,109 | $51,449 | $42,456 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 7,805 | 9,822 | 12,186 | 14,510 | N/A |
| Investments And Advances | 0 | 0 | 13,366 | 0 | 0 |
| Intangibles | 18,651 | 22,408 | 26,516 | 1,704 | 0 |
| Other Non-Current Assets | 264 | 264 | 262 | 444 | 0 |
| TOTAL | $26,720 | $32,494 | $52,330 | $16,658 | $N/A |
| Total Assets | $61,836 | $74,603 | $103,779 | $59,114 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,325 | 675 | 1,134 | 1,226 | 0 |
| Accrued Expenses | 5,847 | 6,767 | 2,125 | 2,381 | N/A |
| TOTAL | $15,067 | $18,636 | $13,864 | $8,865 | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,922 | 1,343 | 695 | 339 | N/A |
| Other Non-Current Liabilities | 267 | 317 | 334 | 551 | 0 |
| TOTAL | $9,887 | $11,054 | $10,840 | $3,796 | $N/A |
| Total Liabilities | $24,954 | $29,690 | $24,704 | $12,661 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,008 | 1,786 | 1,804 | 1,763 | N/A |
| Common Shares | 5 | 18 | 18 | 8 | N/A |
| Retained earnings | -208,139 | -169,604 | -133,004 | -100,774 | N/A |
| Other shareholders' equity | -84 | -79 | -8 | 127,797 | 0 |
| TOTAL | $36,882 | $44,913 | $79,075 | $46,453 | $N/A |
| Total Liabilities And Equity | $61,836 | $74,603 | $103,779 | $59,114 | $0 |